Terug
37
Dagbereik
€ 20,10
€ 21,33
52-Weeksbereik
€ 19,94
€ 41,73
Volume
839.025
50D / 200D Gem.
€ 30,65
/
€ 31,45
Vorige Slotkoers
€ 20,45
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -17,6 | 0,3 |
| P/B | 0,6 | 2,9 |
| ROE % | -3,2 | 3,7 |
| Net Margin % | -9,4 | 3,8 |
| Rev Growth 5Y % | 3,7 | 10,0 |
| D/E | 0,1 | 0,2 |
Koersdoel Analisten
Hold
€ 43,00
+101.8%
Low: € 38,00
High: € 45,00
Forward K/W
26,0
Forward WPA
€ 0,79
WPA Groei (sch.)
+0,0%
Omzet Sch.
620 M
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 1,76
€ 1,73 – € 1,80
|
740 M | 1 |
| FY2029 |
€ 1,30
€ 1,28 – € 1,33
|
680 M | 1 |
| FY2028 |
€ 1,29
€ 1,05 – € 1,47
|
700 M | 4 |
Belangrijkste Punten
Revenue grew 3,69% annually over 5 years — modest growth
Debt/Equity of 0,06 — conservative balance sheet
Generating 38,32M in free cash flow
PEG of 0,39 suggests growth is underpriced
Capital efficient — spends only 5,70% of revenue on capex
Groei
Revenue Growth (5Y)
3,69%
Revenue (1Y)3,55%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-3,19%
ROIC-0,46%
Net Margin-9,39%
Op. Margin-1,90%
Veiligheid
Debt / Equity
0,06
Current Ratio2,98
Interest Coverage0,00
Waardering
P/E Ratio
-17,60
P/B Ratio0,57
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 3,55% | Revenue Growth (3Y) | -5,51% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 3,69% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 593,82M | Net Income (TTM) | -55,76M |
| ROE | -3,19% | ROA | -2,71% |
| Gross Margin | 45,52% | Operating Margin | -1,90% |
| Net Margin | -9,39% | Free Cash Flow (TTM) | 38,32M |
| ROIC | -0,46% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,06 | Current Ratio | 2,98 |
| Interest Coverage | 0,00 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -17,60 | P/B Ratio | 0,57 |
| P/S Ratio | 1,65 | PEG Ratio | 0,39 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 981,57M | Enterprise Value | 812,96M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 593,82M | 573,45M | 665,07M | 555,50M | 513,70M |
| Net Income | -55,76M | -164,90M | -14,26M | -428,96M | 110,75M |
| EPS (Diluted) | -1,22 | -3,09 | -0,22 | -0,15 | -0,39 |
| Gross Profit | 270,28M | 254,62M | 233,26M | 230,62M | 214,51M |
| Operating Income | -11,27M | -29,98M | -82,20M | -24,02M | 3,60M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 2,06B | 2,10B | 2,89B | 3,72B | 1,82B |
| Total Liabilities | 330,70M | 331,07M | 351,22M | 352,74M | 494,18M |
| Shareholders' Equity | 1,73B | 1,77B | 2,53B | 3,36B | 1,33B |
| Total Debt | 111,17M | 70,68M | 60,44M | 49,23M | 94,77M |
| Cash & Equivalents | 279,78M | 310,93M | 678,91M | 658,27M | 227,43M |
| Current Assets | 708,34M | 832,81M | 1,42B | 2,46B | 777,37M |
| Current Liabilities | 237,67M | 204,84M | 210,93M | 230,55M | 345,09M |
Strategiescores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
#494 of 827
Recente Activiteit
Ingestapt
Deep Value Investing (Seth Klarman)
Mar 24, 2026